$VVUS Recent News
Vivus loss narrows as weight-loss sales surge 6:03 p.m. May 5, 2014 - MarketWatch.com
Earnings, deals aid medical supplier, biopharmas on mixed market day 11:32 a.m. Oct. 11, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 1:06 p.m. Oct. 3, 2013 - Russ Britt
What would Grumpy Cat short? 8:56 a.m. July 30, 2013 - The Trading Deck
Hedge funds are buying these stocks right now 2:46 p.m. July 23, 2013 - Insider Monkey
Boardroom peace means a drop in shares for embattled Vivus 1:56 p.m. July 19, 2013 - Russ Britt
Vivus claims allies in proxy war, as does rogue investor 11:09 a.m. July 5, 2013 - Russ Britt
Vivus, rogue shareholder trade salvos as boardroom war heats up 4:52 p.m. June 25, 2013 - Russ Britt
Vivus shares drop as fight for control of company board heats up 4:06 p.m. June 24, 2013 - Russ Britt
5 stocks insiders are buying 2:52 p.m. June 7, 2013 - Insider Monkey
Study shows Vivus' Qsymia may help sleep apnea 9:14 a.m. Nov. 12, 2012 - MarketWatch.com
Vivus shares slide on weak diet-drug sales 1:21 p.m. Nov. 6, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 4:14 p.m. Sept. 21, 2012 - Greg Morcroft
Vivus sees EU regulators rejecting diet drug 1:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 12:07 p.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 8:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 8:33 a.m. Sept. 21, 2012 - MarketWatch.com
Vivus expects Qsiva marketing rejection in Europe 7:48 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus shares fall 11%, top preopen decliner 7:35 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus Suit Preserves Exclusivity Of Qsymia - For Now 2:56 p.m. Today - Seeking Alpha
Vivus sues Actavis 5:59 p.m. June 12, 2014 - Seeking Alpha
EnteroMedics: A Preview of the Weight-Loss Zapper FDA Panel 8:00 a.m. June 12, 2014 - TheStreet.com
Despite the Stumble, OREX Stock & Contrave Are Still Compelling 7:42 a.m. June 12, 2014 - InvestorPlace.com
Orexigen Irony: No VIVUS Bounce 4:25 p.m. June 11, 2014 - 247WallSt.com
Orexigen Obesity Drug Decision Delayed By FDA 10:55 a.m. June 11, 2014 - Investors Business Daily
Top Swing Trade Ideas for Wednesday June 11: Facebook, Vivus, More 9:37 a.m. June 11, 2014 - TheStreet.com
FDA Delays Decision On Orexigen Anti-Obesity Drug - What This Means To The Stock 9:28 a.m. June 11, 2014 - Seeking Alpha
Orexigen Shares Drop as FDA Delays Approval 7:17 a.m. June 11, 2014 - The Wall Street Journal Interactive Edition
FDA Delays Decision on Orexigen Obesity Pill by 3 Months 6:48 a.m. June 11, 2014 - TheStreet.com
Orexigen Investors Hope For FDA Approval 1:22 p.m. June 10, 2014 - Seeking Alpha
Orexigen Could Be A Double Edged Sword For Arena 5:22 p.m. June 9, 2014 - Seeking Alpha
Is Vivus About To Get Squeezed? 1:54 p.m. June 9, 2014 - benzinga.com
Binary event looming for Orexigen 1:54 p.m. June 9, 2014 - Seeking Alpha
Orexigen: 'Goldilocks' Obesity Pill Awaits FDA Approval Decision Wednesday 12:43 p.m. June 9, 2014 - TheStreet.com
Arena Pharmaceuticals: Strong Sell On Multiple Red Flags 1:15 p.m. June 6, 2014 - Seeking Alpha
Investors Are Shorting VIVUS (VVUS) Stock: Is A Short Cover Coming? - Tale of the Tape 9:00 a.m. June 3, 2014 - Zacks.com
Belviq Sales Climb - Are Ads Effective? 4:46 p.m. May 30, 2014 - Seeking Alpha
A Vivus Buyout? Fat Chance And A Good Time To Short 12:30 p.m. May 30, 2014 - Seeking Alpha
Cramer's Lightning Round - Linn Energy Has Lost Its Way (5/29/14) 6:28 a.m. May 30, 2014 - Seeking Alpha
VIVUS Files Lawsuit Against Actavis for Infringement of Qsymia Patents 4:33 p.m. June 12, 2014 - Marketwire
VIVUS to Present at Upcoming Investor Conference 7:01 a.m. June 12, 2014 - Marketwire
Technical Data on Top Gainers -- Research on VIVUS, Magnum Hunter Resources, Xenoport, and Media General 7:10 a.m. May 29, 2014 - PR Newswire - PRF
Avanafil Clinical Data to Be Presented at American Urological Association 7:02 a.m. May 19, 2014 - Marketwire
VIVUS Announces Qsymia Presentation at the American Association of Clinical Endocrinologists (AACE) 7:02 a.m. May 15, 2014 - Marketwire
VIVUS to Present at Upcoming Investor Conference 4:32 p.m. May 8, 2014 - Marketwire
Active Stocks at a Glance -- Research on Oi S.A., Hyperdynamics, Vivus, and EMC Corp. 8:00 a.m. May 7, 2014 - PR Newswire - PRF
VIVUS Reports First Quarter 2014 Financial Results 6:25 a.m. May 7, 2014 - Marketwire
VIVUS Announces Date of First Quarter 2014 Update and Financial Results Conference Call 7:02 a.m. April 29, 2014 - GlobeNewswire
Avanafil Clinical Data to Be Presented at European Association of Urology 7:01 a.m. April 11, 2014 - Marketwire
Three VIVUS Directors Not Standing for Re-Election 5:01 p.m. April 8, 2014 - Marketwire
Food & Beverage Companies Advancing in the Consumer Goods Sector - Company Focuses on Strategic Growth Initiatives for 2014 and Beyond 9:05 a.m. April 3, 2014 - PR Newswire - PRF
VIVUS to Present at Upcoming Investor Conference 7:02 a.m. April 3, 2014 - Marketwire
Newly Published Review Article Summarizes Cardiovascular Benefit-Risk Profile of Qsymia 7:03 a.m. March 25, 2014 - Marketwire
Pre-Market Pulse - Health Care Sector Stocks -- Research on Exelixis, StemCells, Dendreon, and Vivus 10:46 a.m. March 24, 2014 - PR Newswire - PRF
Shari Belafonte Partners With VIVUS to Encourage Adults to Speak With Their Doctors About Losing Weight and Treatment Options Now Available 7:02 a.m. March 19, 2014 - Marketwire
Health & Nutritional Stocks in the News - Company Expands Product Diversity Based on Growing Consumer Demand 10:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
VIVUS Reports Fourth Quarter and Year-End 2013 Financial Results 5:00 p.m. Feb. 24, 2014 - GlobeNewswire
VIVUS Announces Date of Fourth Quarter and Year End 2013 Financial Results and Conference Call 8:00 a.m. Feb. 19, 2014 - GlobeNewswire
VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (avanafil) 8:05 a.m. Jan. 21, 2014 - PR Newswire - PRF
Vivus loss narrows as weight-loss sales surge 6:03 p.m. May 5, 2014 - MarketWatch.com
Earnings, deals aid medical supplier, biopharmas on mixed market day 11:32 a.m. Oct. 11, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 1:06 p.m. Oct. 3, 2013 - Russ Britt
What would Grumpy Cat short? 8:56 a.m. July 30, 2013 - The Trading Deck
Hedge funds are buying these stocks right now 2:46 p.m. July 23, 2013 - Insider Monkey
Boardroom peace means a drop in shares for embattled Vivus 1:56 p.m. July 19, 2013 - Russ Britt
Vivus claims allies in proxy war, as does rogue investor 11:09 a.m. July 5, 2013 - Russ Britt
Vivus, rogue shareholder trade salvos as boardroom war heats up 4:52 p.m. June 25, 2013 - Russ Britt
Vivus shares drop as fight for control of company board heats up 4:06 p.m. June 24, 2013 - Russ Britt
5 stocks insiders are buying 2:52 p.m. June 7, 2013 - Insider Monkey
Study shows Vivus' Qsymia may help sleep apnea 9:14 a.m. Nov. 12, 2012 - MarketWatch.com
Vivus shares slide on weak diet-drug sales 1:21 p.m. Nov. 6, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 4:14 p.m. Sept. 21, 2012 - Greg Morcroft
Vivus sees EU regulators rejecting diet drug 1:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 12:07 p.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 8:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 8:33 a.m. Sept. 21, 2012 - MarketWatch.com
Vivus expects Qsiva marketing rejection in Europe 7:48 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus shares fall 11%, top preopen decliner 7:35 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus Suit Preserves Exclusivity Of Qsymia - For Now 2:56 p.m. Today - Seeking Alpha
Vivus sues Actavis 5:59 p.m. June 12, 2014 - Seeking Alpha
EnteroMedics: A Preview of the Weight-Loss Zapper FDA Panel 8:00 a.m. June 12, 2014 - TheStreet.com
Despite the Stumble, OREX Stock & Contrave Are Still Compelling 7:42 a.m. June 12, 2014 - InvestorPlace.com
Orexigen Irony: No VIVUS Bounce 4:25 p.m. June 11, 2014 - 247WallSt.com
Orexigen Obesity Drug Decision Delayed By FDA 10:55 a.m. June 11, 2014 - Investors Business Daily
Top Swing Trade Ideas for Wednesday June 11: Facebook, Vivus, More 9:37 a.m. June 11, 2014 - TheStreet.com
FDA Delays Decision On Orexigen Anti-Obesity Drug - What This Means To The Stock 9:28 a.m. June 11, 2014 - Seeking Alpha
Orexigen Shares Drop as FDA Delays Approval 7:17 a.m. June 11, 2014 - The Wall Street Journal Interactive Edition
FDA Delays Decision on Orexigen Obesity Pill by 3 Months 6:48 a.m. June 11, 2014 - TheStreet.com
Orexigen Investors Hope For FDA Approval 1:22 p.m. June 10, 2014 - Seeking Alpha
Orexigen Could Be A Double Edged Sword For Arena 5:22 p.m. June 9, 2014 - Seeking Alpha
Is Vivus About To Get Squeezed? 1:54 p.m. June 9, 2014 - benzinga.com
Binary event looming for Orexigen 1:54 p.m. June 9, 2014 - Seeking Alpha
Orexigen: 'Goldilocks' Obesity Pill Awaits FDA Approval Decision Wednesday 12:43 p.m. June 9, 2014 - TheStreet.com
Arena Pharmaceuticals: Strong Sell On Multiple Red Flags 1:15 p.m. June 6, 2014 - Seeking Alpha
Investors Are Shorting VIVUS (VVUS) Stock: Is A Short Cover Coming? - Tale of the Tape 9:00 a.m. June 3, 2014 - Zacks.com
Belviq Sales Climb - Are Ads Effective? 4:46 p.m. May 30, 2014 - Seeking Alpha
A Vivus Buyout? Fat Chance And A Good Time To Short 12:30 p.m. May 30, 2014 - Seeking Alpha
Cramer's Lightning Round - Linn Energy Has Lost Its Way (5/29/14) 6:28 a.m. May 30, 2014 - Seeking Alpha
VIVUS Files Lawsuit Against Actavis for Infringement of Qsymia Patents 4:33 p.m. June 12, 2014 - Marketwire
VIVUS to Present at Upcoming Investor Conference 7:01 a.m. June 12, 2014 - Marketwire
Technical Data on Top Gainers -- Research on VIVUS, Magnum Hunter Resources, Xenoport, and Media General 7:10 a.m. May 29, 2014 - PR Newswire - PRF
Avanafil Clinical Data to Be Presented at American Urological Association 7:02 a.m. May 19, 2014 - Marketwire
VIVUS Announces Qsymia Presentation at the American Association of Clinical Endocrinologists (AACE) 7:02 a.m. May 15, 2014 - Marketwire
VIVUS to Present at Upcoming Investor Conference 4:32 p.m. May 8, 2014 - Marketwire
Active Stocks at a Glance -- Research on Oi S.A., Hyperdynamics, Vivus, and EMC Corp. 8:00 a.m. May 7, 2014 - PR Newswire - PRF
VIVUS Reports First Quarter 2014 Financial Results 6:25 a.m. May 7, 2014 - Marketwire
VIVUS Announces Date of First Quarter 2014 Update and Financial Results Conference Call 7:02 a.m. April 29, 2014 - GlobeNewswire
Avanafil Clinical Data to Be Presented at European Association of Urology 7:01 a.m. April 11, 2014 - Marketwire
Three VIVUS Directors Not Standing for Re-Election 5:01 p.m. April 8, 2014 - Marketwire
Food & Beverage Companies Advancing in the Consumer Goods Sector - Company Focuses on Strategic Growth Initiatives for 2014 and Beyond 9:05 a.m. April 3, 2014 - PR Newswire - PRF
VIVUS to Present at Upcoming Investor Conference 7:02 a.m. April 3, 2014 - Marketwire
Newly Published Review Article Summarizes Cardiovascular Benefit-Risk Profile of Qsymia 7:03 a.m. March 25, 2014 - Marketwire
Pre-Market Pulse - Health Care Sector Stocks -- Research on Exelixis, StemCells, Dendreon, and Vivus 10:46 a.m. March 24, 2014 - PR Newswire - PRF
Shari Belafonte Partners With VIVUS to Encourage Adults to Speak With Their Doctors About Losing Weight and Treatment Options Now Available 7:02 a.m. March 19, 2014 - Marketwire
Health & Nutritional Stocks in the News - Company Expands Product Diversity Based on Growing Consumer Demand 10:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
VIVUS Reports Fourth Quarter and Year-End 2013 Financial Results 5:00 p.m. Feb. 24, 2014 - GlobeNewswire
VIVUS Announces Date of Fourth Quarter and Year End 2013 Financial Results and Conference Call 8:00 a.m. Feb. 19, 2014 - GlobeNewswire
VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (avanafil) 8:05 a.m. Jan. 21, 2014 - PR Newswire - PRF
